Mark Krailo

Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone

Holcombe E. Grier, Mark Krailo, Nancy J. Tarbell et al. · New England Journal of Medicine · 2003 · 1.3K citations

Medicine, Oncology, Pharmacology +17

Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

Richard B. Womer, Daniel C. West, Mark Krailo et al. · Journal of Clinical Oncology · 2012 · 756 citations · Full text

Medicine, Oncology, Surgery +14

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2008 · 748 citations · Full text

Medicine, Oncology, Pharmacology +14

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

Sigbjørn Smeland, Stefan Bielack, Jeremy Whelan et al. · European Journal of Cancer · 2019 · 726 citations · Full text

Medicine, Oncology, Surgery +17

Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2005 · 719 citations · Full text

Medicine, Oncology, Pharmacology +15